Literature DB >> 12614062

Ocular safety of INS365 ophthalmic solution, a P2Y2 agonist, in patients with mild to moderate dry eye disease.

Benjamin R Yerxa1, Mohan Mundasad, Robin N Sylvester, JoAnn C Garden, Mark Cooper, Donald J Kellerman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12614062     DOI: 10.1007/978-1-4615-0717-8_180

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  7 in total

Review 1.  [Dry eye. An update on epidemiology, diagnosis, therapy and new concepts].

Authors:  F Schirra; K W Ruprecht
Journal:  Ophthalmologe       Date:  2004-01       Impact factor: 1.059

Review 2.  Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system.

Authors:  Vera Jankowski; Markus van der Giet; Harald Mischak; Michael Morgan; Walter Zidek; Joachim Jankowski
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

Review 3.  Recent advances in the management of ocular complications of Sjögren's syndrome.

Authors:  Michael Samarkos; Haralampos M Moutsopoulos
Journal:  Curr Allergy Asthma Rep       Date:  2005-07       Impact factor: 4.919

Review 4.  Dry eye: diagnosis and current treatment strategies.

Authors:  Paul D O'Brien; Louis M T Collum
Journal:  Curr Allergy Asthma Rep       Date:  2004-07       Impact factor: 4.919

Review 5.  P2Y2 receptor agonists for the treatment of dry eye disease: a review.

Authors:  Oliver C F Lau; Chameen Samarawickrama; Simon E Skalicky
Journal:  Clin Ophthalmol       Date:  2014-01-30

6.  Tear film lipid layer increase after diquafosol instillation in dry eye patients with meibomian gland dysfunction: a randomized clinical study.

Authors:  Shima Fukuoka; Reiko Arita
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

7.  Preliminary effects of oral uridine on the ocular surface in dry eye patients.

Authors:  Ki Cheol Chang; Joo Youn Oh; Youn Seok In; Mee Kum Kim; Ki Cheul Shin; Won Ryang Wee; Jin Hak Lee; Myung Gyu Park
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.